Hide metadata

dc.date.accessioned2020-04-20T11:38:38Z
dc.date.available2020-08-27T22:46:29Z
dc.date.created2019-08-27T16:01:14Z
dc.date.issued2019
dc.identifier.citationCeulemans, Michael Lupattelli, Angela Nordeng, Hedvig Marie Egeland Odalovic, Marina Twigg, Michael J. Foulon, Veerle . Women’s Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists. Current pharmaceutical design. 2019, 25(5), 469-482
dc.identifier.urihttp://hdl.handle.net/10852/74640
dc.description.abstractBackground: During pregnancy, women might weigh the benefits of treatment against potential risks to the unborn child. However, non-adherence to necessary treatment can adversely affect both mother and child. To optimize pregnant women’s beliefs and medication adherence, community pharmacists are ideally positioned to play an important role in primary care. Objective: This narrative review aimed to summarize the evidence on 1) pregnant women’s beliefs, 2) medication adherence in pregnancy and 3) community pharmacists’ counselling during pregnancy. Methods: Three search strategies were used in Medline and Embase to find original studies evaluating women’s beliefs, medication adherence and community pharmacists’ counselling during pregnancy. All original descriptive and analytic epidemiological studies performed in Europe, North America and Australia, written in English and published from 2000 onwards were included. Results: We included 14 studies reporting on women’s beliefs, 11 studies on medication adherence and 9 on community pharmacists’ counselling during pregnancy. Women are more reluctant to use medicines during pregnancy and tend to overestimate the teratogenic risk of medicines. The risk perception varies with the type of medicine, level of health literacy, education level and occupation. Furthermore, low medication adherence during pregnancy is common. Finally, limited evidence showed that the current community pharmacists’ counselling is insufficient. Barriers hindering pharmacists are insufficient knowledge and limited access to reliable information. Conclusion: Concerns about medication use and non-adherence are widespread among pregnant women. Community pharmacists’ counselling during pregnancy is insufficient. Further education, training and research are required to support community pharmacists in fulfilling all the opportunities they have when counselling pregnant women.en_US
dc.languageEN
dc.publisherBentham Science Publishers, Ltd.
dc.titleWomen’s Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacistsen_US
dc.typeJournal articleen_US
dc.creator.authorCeulemans, Michael
dc.creator.authorLupattelli, Angela
dc.creator.authorNordeng, Hedvig Marie Egeland
dc.creator.authorOdalovic, Marina
dc.creator.authorTwigg, Michael J.
dc.creator.authorFoulon, Veerle
cristin.unitcode185,15,23,10
cristin.unitnameGalenisk farmasi og samfunnsfarmasi
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1
dc.identifier.cristin1719243
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Current pharmaceutical design&rft.volume=25&rft.spage=469&rft.date=2019
dc.identifier.jtitleCurrent pharmaceutical design
dc.identifier.volume25
dc.identifier.issue5
dc.identifier.startpage469
dc.identifier.endpage482
dc.identifier.doihttp://dx.doi.org/10.2174/1381612825666190321110420
dc.identifier.urnURN:NBN:no-77741
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1381-6128
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/74640/2/Review%2BCurr%2BPharm%2BDesign_Ceulemans%2Bet%2Bal_finalversion.pdf
dc.type.versionAcceptedVersion


Files in this item

Appears in the following Collection

Hide metadata